These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Insights into molecular interactions between CaM and its inhibitors from molecular dynamics simulations and experimental data. González-Andrade M; Rodríguez-Sotres R; Madariaga-Mazón A; Rivera-Chávez J; Mata R; Sosa-Peinado A; Del Pozo-Yauner L; Arias-Olguín II J Biomol Struct Dyn; 2016; 34(1):78-91. PubMed ID: 25702612 [TBL] [Abstract][Full Text] [Related]
7. Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking methods. Leherte L; Petit A; Jacquemin D; Vercauteren DP; Laurent AD J Comput Aided Mol Des; 2018 Nov; 32(11):1295-1313. PubMed ID: 30368623 [TBL] [Abstract][Full Text] [Related]
8. Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3. Diehl C; Engström O; Delaine T; Håkansson M; Genheden S; Modig K; Leffler H; Ryde U; Nilsson UJ; Akke M J Am Chem Soc; 2010 Oct; 132(41):14577-89. PubMed ID: 20873837 [TBL] [Abstract][Full Text] [Related]
9. The carbohydrate-binding site in galectin-3 is preorganized to recognize a sugarlike framework of oxygens: ultra-high-resolution structures and water dynamics. Saraboji K; Håkansson M; Genheden S; Diehl C; Qvist J; Weininger U; Nilsson UJ; Leffler H; Ryde U; Akke M; Logan DT Biochemistry; 2012 Jan; 51(1):296-306. PubMed ID: 22111949 [TBL] [Abstract][Full Text] [Related]
11. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3. Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013 [TBL] [Abstract][Full Text] [Related]
12. Binding of Gold(III) Porphyrin by the Pro-metastatic Regulatory Protein Human Galectin-3. Bogoeva V; Rangelov M; Todorova N; Lambert A; Bridot C; Yordanova A; Roos G; Grandjean C; Bouckaert J Molecules; 2019 Dec; 24(24):. PubMed ID: 31842510 [TBL] [Abstract][Full Text] [Related]
13. Galectin-3 - A novel ligand of complement protein C1q. Radulova G; Kapogianni A; Cholakova G; Iliev S; Ivanova A; Bogoeva V; Tsacheva I Int J Biol Macromol; 2024 Mar; 262(Pt 2):129930. PubMed ID: 38325676 [TBL] [Abstract][Full Text] [Related]
14. Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approach. Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA Mol Divers; 2022 Jun; 26(3):1697-1714. PubMed ID: 34482478 [TBL] [Abstract][Full Text] [Related]
15. Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2. Athanasiou C; Vasilakaki S; Dellis D; Cournia Z J Comput Aided Mol Des; 2018 Jan; 32(1):21-44. PubMed ID: 29119352 [TBL] [Abstract][Full Text] [Related]
17. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure. Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the galectin-1 carbohydrate recognition domain in terms of solvent occupancy. Di Lella S; Martí MA; Alvarez RM; Estrin DA; Ricci JC J Phys Chem B; 2007 Jun; 111(25):7360-6. PubMed ID: 17523619 [TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations. Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525 [TBL] [Abstract][Full Text] [Related]